Exploring Alternative Viral Vector Methods for Delivering Gene Therapies

Time: 3:45 pm
day: Day Two


  • An overview of the immunogenicity issues surrounding AAV vectors and some different approaches to overcome this
  • How to overcome immune barriers to gene therapy delivery via a novel viral vector method
  • Discussing some of the regulatory challenges unique to developing novel viral vectors